BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37747536)

  • 1. Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score.
    Hao YW; Zhang Y; Guo HP; Xu W; Bai X; Zhao J; Ding XH; Gao S; Cui MQ; Liu BC; Ye HY; Wang HY
    Abdom Radiol (NY); 2023 Dec; 48(12):3714-3727. PubMed ID: 37747536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance and Interreader Agreement of the MRI Clear Cell Likelihood Score for Characterization of cT1a and cT1b Solid Renal Masses: An External Validation Study.
    Dunn M; Linehan V; Clarke SE; Keough V; Nelson R; Costa AF
    AJR Am J Roentgenol; 2022 Nov; 219(5):793-803. PubMed ID: 35642765
    [No Abstract]   [Full Text] [Related]  

  • 3. Multicenter Evaluation of Multiparametric MRI Clear Cell Likelihood Scores in Solid Indeterminate Small Renal Masses.
    Schieda N; Davenport MS; Silverman SG; Bagga B; Barkmeier D; Blank Z; Curci NE; Doshi AM; Downey RT; Edney E; Granader E; Gujrathi I; Hibbert RM; Hindman N; Walsh C; Ramsay T; Shinagare AB; Pedrosa I
    Radiology; 2022 Jun; 303(3):590-599. PubMed ID: 35289659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of diagnostic performance of Clear Cell Likelihood Score v1.0 and v2.0 for clear renal cell carcinoma].
    Hao Y; Gao S; Zhang X; Cui M; Ding X; Wang H; Yang D; Ye H; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):800-806. PubMed ID: 37313822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of clear cell likelihood scores in characterizing solid renal masses at multiparametric MRI: an external validation study.
    Ibrahim A; Pelsser V; Anidjar M; Kaitoukov Y; Camlioglu E; Moosavi B
    Abdom Radiol (NY); 2023 Mar; 48(3):1033-1043. PubMed ID: 36639532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of clear cell likelihood score in differentiation between renal oncocytoma and clear cell renal cell carcinoma].
    Cui MQ; He B; Xu W; Hao YW; Ding XH; Wang S; Bai X; Liu BC; Ye HY; Wang HY
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3779-3785. PubMed ID: 36517429
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging.
    Johnson BA; Kim S; Steinberg RL; de Leon AD; Pedrosa I; Cadeddu JA
    Urol Oncol; 2019 Dec; 37(12):941-946. PubMed ID: 31540830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging.
    Steinberg RL; Rasmussen RG; Johnson BA; Ghandour R; De Leon AD; Xi Y; Yokoo T; Kim S; Kapur P; Cadeddu JA; Pedrosa I
    Eur Radiol; 2021 Jan; 31(1):314-324. PubMed ID: 32770377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Differentiation of Minimal Fat Angiomyolipoma from Clear Cell Renal Cell Carcinoma.
    Li H; Li A; Zhu H; Hu Y; Li J; Xia L; Hu D; Kamel IR; Li Z
    Acad Radiol; 2019 May; 26(5):632-639. PubMed ID: 30087067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating renal epithelioid angiomyolipoma from clear cell carcinoma: using a radiomics model combined with CT imaging characteristics.
    Kim TM; Ahn H; Lee HJ; Kim MG; Cho JY; Hwang SI; Kim SY
    Abdom Radiol (NY); 2022 Aug; 47(8):2867-2880. PubMed ID: 35697856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model development and external validation.
    Matsumoto S; Arita Y; Yoshida S; Fukushima H; Kimura K; Yamada I; Tanaka H; Yagi F; Yokoyama M; Matsuoka Y; Oya M; Tateishi U; Jinzaki M; Fujii Y
    Abdom Radiol (NY); 2022 Jun; 47(6):2178-2186. PubMed ID: 35426498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Multiparametric Renal CT Algorithm for Diagnosis of Clear Cell Renal Cell Carcinoma Among Small (≤ 4 cm) Solid Renal Masses.
    Al Nasibi K; Pickovsky JS; Eldehimi F; Flood TA; Lavallee LT; Tsampalieros AK; Schieda N
    AJR Am J Roentgenol; 2022 Nov; 219(5):814-823. PubMed ID: 35766532
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
    Lee HS; Hong H; Jung DC; Park S; Kim J
    Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance.
    Rasmussen RG; Xi Y; Sibley RC; Lee CJ; Cadeddu JA; Pedrosa I
    AJR Am J Roentgenol; 2022 Jan; 218(1):101-110. PubMed ID: 34286596
    [No Abstract]   [Full Text] [Related]  

  • 15. External Validation of a Five-Tiered CT Algorithm for the Diagnosis of Clear Cell Renal Cell Carcinoma: A Retrospective Five-Reader Study.
    Lemieux S; Shen L; Liang T; Lo E; Chu Y; Kamaya A; Tse JR
    AJR Am J Roentgenol; 2023 Sep; 221(3):334-343. PubMed ID: 37162037
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiation between fat-poor angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    Ye J; Xu Q; Wang SA; Zheng J; Zhu QQ; Dou WQ
    Abdom Radiol (NY); 2020 Feb; 45(2):512-519. PubMed ID: 31705246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.
    Nie P; Yang G; Wang Z; Yan L; Miao W; Hao D; Wu J; Zhao Y; Gong A; Cui J; Jia Y; Niu H
    Eur Radiol; 2020 Feb; 30(2):1274-1284. PubMed ID: 31506816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoexponential, biexponential, and stretched exponential diffusion-weighted imaging models: Quantitative biomarkers for differentiating renal clear cell carcinoma and minimal fat angiomyolipoma.
    Li H; Liang L; Li A; Hu Y; Hu D; Li Z; Kamel IR
    J Magn Reson Imaging; 2017 Jul; 46(1):240-247. PubMed ID: 27859853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early dark cortical band sign on CT for differentiating clear cell renal cell carcinoma from fat poor angiomyolipoma and detecting peritumoral pseudocapsule.
    Ogawa Y; Morita S; Takagi T; Yoshida K; Tanabe K; Nagashima Y; Nishina Y; Sakai S
    Eur Radiol; 2021 Aug; 31(8):5990-5997. PubMed ID: 33559699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.